A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma

1995811 citationsJournal Articlebronze Open Access

Authors

Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire · Hôpital Jean-Verdier

Abstract

In a group of patients with unresectable hepatocellular carcinoma but without severe liver disease, lipiodol chemoembolization reduced tumor growth, often caused acute liver failure, and did not significantly improve survival.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Hepatitis C virus research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 332, Issue 19, pp. 1256-1261

DOI: 10.1056/nejm199505113321903

Field-Weighted Citation Impact: 20.68